Accelerated Clinical Trials (ACT)

Get Started

Get Started

Accelerated Clinical Trials (ACT) is an enterprise agentic AI workflow platform designed to streamline and automate the clinical trial process. By integrating real-world and proprietary data with advanced AI workflows, ACT accelerates processes like study design, feasibility analysis, and operational monitoring. This results in shorter trial timelines by 10-20 months, significantly reduced trial costs, and improved decision-making, empowering organizations to bring therapies to market faster.

Request a Demo

ACT Key Benefits

Accelerate Trial Time to Market

Improved Likelihood of Success

Achieve Significant Cost Savings

Gain a Competitive Advantage

AI-Driven Study Design & Feasibility

ACT's AI-powered tools, including the Design, Feasibility, and Writing Assistants, streamline study design and protocol development, cutting timelines by up to 50% and reducing costly amendments. Recruitment and site selection are optimized with automated patient matching and site validation, saving millions and shortening timelines by 25–50%. Real-time monitoring and centralized workflows further reduce trial durations by 6–19 months, maximizing revenue potential.

Advanced Predictive Modeling

ACT reduces costly amendments by up to 50% through optimized study design and feasibility validation, ensuring practical, goal-aligned protocols. Automated document creation and real-time monitoring cut timelines and proactively address issues, while streamlined site validation and data integration minimize errors, saving millions in operational costs. These efficiencies ensure significant, predictable savings across every study iteration.

Optimized Study Design and Feasibility Validation

ACT's advanced predictive modeling delivers highly accurate probability forecasts, improving trial success rates by up to 30% compared to traditional estimation methods. By leveraging AI-driven insights, ACT provides a deeper understanding of trial feasibility and potential challenges, enabling proactive adjustments that enhance outcomes. This precision reduces risks, improves enrollment goal achievement, and ensures more efficient, successful trials.

Competitive Trial Analysis

ACT's Competitive Trial Agent optimizes trial effectiveness by analyzing and comparing study design parameters, while ConcertAI’s decade of expertise in customizable AI agents, powered by CARAai, delivers tailored insights. Recognized as a top Clinical Trial AI vendor for 2026 by Frost & Sullivan, ConcertAI drives innovation and competitive advantage.

Cohort Creation & Optimization

Translate protocol criteria into real-world patient cohorts using AI tools and curated data to assess feasibility and optimize patient selection early.

ACT COHORT CREATION

Study Design Optimization

Optimize protocols with predictive AI, mitigate amendment risks, and save $1-6M per trial by aligning designs with real-world data and standards of care.

ACT - Study Design Optimization

Site Selection Optimization

Prioritize high-performing sites using AI-driven tools, reducing non-productive sites by 25% and site activation timelines by 1-2 months.

ACT - Site Selection Optimization

Site Start-up
& Activation

Automates trial documentation revisions to reduce delays
Enhances site activation timelines with AI-driven workflows
Simplifies contract and regulatory processes for faster start-up

Study Management & Monitoring

Monitors site performance & alignment with trial goals
Generates automated remediation strategies for underperforming sites
Provides real-time insights to mitigate operational risks

Accelerate Your Next Trial With ConcertAI's ACT

Design smarter, activate faster, and recruit the right patients with agentic AI built for end-to-end clinical development.

Request a Demo